Similar articles

• [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].

  Tsukamura M, Mizuno S, Murata H, Oshima T. Tsukamura M, et al. Kekkaku. 1975 May;50(4-5):123-30. Kekkaku. 1975. PMID: 49449 Japanese. No abstract available.
• [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].

  Tsukamura M. Tsukamura M. Kekkaku. 1971 Oct;46(10):405-8. Kekkaku. 1971. PMID: 4112456 Japanese. No abstract available.
• [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].

  [No authors listed] [No authors listed] Kekkaku. 1971 Nov;46(11):423-8. Kekkaku. 1971. PMID: 4335256 Japanese. No abstract available.
• [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].

  Tsukamura M. Tsukamura M. Kekkaku. 1977 Apr;52(4):171-5. Kekkaku. 1977. PMID: 69737 Review. Japanese. No abstract available.
• Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.

  Mitchison DA. Mitchison DA. Soc Appl Bacteriol Symp Ser. 1996;25:72S-80S. Soc Appl Bacteriol Symp Ser. 1996. PMID: 8972122 Review. No abstract available.